Strybol Wout Pharma SRL
Strybol Wout Pharma reported total assets of €2.17m at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jul 2026).
By total assets for 2025, Strybol Wout Pharma ranks among the 1,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Strybol Wout Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -62 % Total assets +1257 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Strybol Wout Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 22 Jul 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Strybol Wout Pharma's financial analysis
- Solvency2.6%sector median: 54.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Strybol Wout Pharma
Strybol Wout Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0712.514.587
- VAT number
- BE0712514587
- Peppol
- Registered · 0208:0712514587 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Oct 2018
- Registered office
- 8310 Bruges
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Strybol Wout Pharma (SRL) has been based in Bruges since 2018, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 155,593 € and equity of 56,774 €; its revenue is not published. Its solvency stands at 2.6%, below the median of its sector (54.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Strybol Wout Pharma
Companies in the same business, of comparable size and area, outside its group.
- Ares4S Other business support service activities n.e.c. Nijlen · balance sheet €2.17m
- CR Pharma Other business support service activities n.e.c. Harelbeke · balance sheet €2.16m
- Jogi Invest Other business support service activities n.e.c. Denderleeuw · balance sheet €2.14m
- Beton Brut Other business support service activities n.e.c. Ghent · balance sheet €2.13m
- Belart & Co Other business support service activities n.e.c. Wavre · balance sheet €2.13m
- Aligno Other business support service activities n.e.c. Mol · balance sheet €2.21m
- Brawo Other business support service activities n.e.c. Sint-Laureins · balance sheet €2.11m
- Vincent De Moor Other business support service activities n.e.c. Antwerp · balance sheet €2.23m
Frequently asked questions about Strybol Wout Pharma
What is the revenue of Strybol Wout Pharma?
Strybol Wout Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Strybol Wout Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0712514587 for Strybol Wout Pharma, if the company is VAT-registered. Its company number (CBE) is 0712.514.587.
Where is the registered office of Strybol Wout Pharma?
According to the CBE register, the registered office of Strybol Wout Pharma is in 8310 Bruges.
What is the equity of Strybol Wout Pharma?
At the close of the 2025 financial year, the equity of Strybol Wout Pharma amounts to 56,774 €, a solvency of 2.6% of total assets.
Who manages Strybol Wout Pharma?
The register lists 1 active mandates at Strybol Wout Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Strybol Wout Pharma within its sector?
By total assets for 2025, Strybol Wout Pharma ranks among the 1,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year.
The full file of Strybol Wout Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →